171 related articles for article (PubMed ID: 2022074)
1. Cardiac output and the blood pressure increase in deoxycorticosterone acetate-salt hypertension after nicotine infusion.
Passmore JC; Jimenez AE; Pierce WM
Clin Exp Hypertens A; 1991; 13(1):83-102. PubMed ID: 2022074
[TBL] [Abstract][Full Text] [Related]
2. Separate hemodynamic roles for chloride and sodium in deoxycorticosterone acetate-salt hypertension.
Passmore JC; Jimenez AE
Proc Soc Exp Biol Med; 1990 Jul; 194(3):283-8. PubMed ID: 2356192
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension.
Kohlmann O; Ginoza M; Cezaretti ML; Zanella MT; Ribeiro AB; Tavares A; Ramos OL; Leeman SE; Gavras I; Gavras H
Hypertension; 1995 Dec; 26(6 Pt 2):1186-9. PubMed ID: 7498993
[TBL] [Abstract][Full Text] [Related]
4. Development of hypertension in animals with reduced total peripheral resistance.
Huang M; Hester RL; Coleman TG; Smith MJ; Guyton AC
Hypertension; 1992 Dec; 20(6):828-33. PubMed ID: 1452299
[TBL] [Abstract][Full Text] [Related]
5. Nicotine impairs reflex renal nerve and respiratory activity in deoxycorticosterone acetate-salt rats.
Whitescarver SA; Roberts AM; Stremel RW; Jimenez AE; Passmore JC
Hypertension; 1991 Feb; 17(2):179-86. PubMed ID: 1991650
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic characteristics of conscious deoxycorticosterone acetate hypertensive rats.
Shimamoto H; Iriuchijima J
Jpn J Physiol; 1987; 37(2):243-54. PubMed ID: 2957535
[TBL] [Abstract][Full Text] [Related]
7. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
O'Donaughy TL; Qi Y; Brooks VL
Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
[TBL] [Abstract][Full Text] [Related]
8. Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice.
Obst M; Gross V; Luft FC
J Hypertens; 2004 Oct; 22(10):1889-94. PubMed ID: 15361759
[TBL] [Abstract][Full Text] [Related]
9. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
Fujita T; Sato Y
Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
[TBL] [Abstract][Full Text] [Related]
10. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
Katholi RE; Naftilan AJ; Bishop SP; Oparil S
Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
12. Importance of chloride for deoxycorticosterone acetate-salt hypertension in the rat.
Passmore JC; Whitescarver SA; Ott CE; Kotchen TA
Hypertension; 1985; 7(3 Pt 2):I115-20. PubMed ID: 3997231
[TBL] [Abstract][Full Text] [Related]
13. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension.
Kohzuki M; Abe K; Yasujima M; Kasai Y; Hiwatari M; Kanazawa M; Sato M; Omata K; Kudo K; Takeuchi K
Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826
[TBL] [Abstract][Full Text] [Related]
15. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelin and vasopressin in DOCA-salt hypertension.
Yu M; Gopalakrishnan V; McNeill JR
Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
[TBL] [Abstract][Full Text] [Related]
17. Chronic angiotensin blockade with candesartan cilexetil in DOCA/salt hypertensive rats reduces cardiac hypertrophy and coronary resistance without affecting blood pressure.
Fujita H; Takeda K; Miki S; Morimoto S; Kawa T; Uchida A; Itoh H; Nakata T; Sasaki S; Nakagawa M
Hypertens Res; 1997 Dec; 20(4):263-7. PubMed ID: 9453261
[TBL] [Abstract][Full Text] [Related]
18. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats.
Klarr SA; Keep RF; Betz AL
Am J Physiol; 1995 Feb; 268(2 Pt 2):H646-52. PubMed ID: 7864190
[TBL] [Abstract][Full Text] [Related]
19. Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent?
Watts SW; Harris B
Gen Pharmacol; 1999 Dec; 33(6):439-47. PubMed ID: 10647769
[TBL] [Abstract][Full Text] [Related]
20. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
